TickerFacts.

TherapeuticsMD, Inc. (TXMD): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$1.40M
Year ended 2022-12-31
-39.6%
3-year compound annual growth
-11.9%
5-year compound annual growth
+0.4%
10-year compound annual growth
$15.97M2011-12-31: $947.1K2012-12-31: $1.35M2013-12-31: $1.96M2014-12-31: $3.67M2015-12-31: $4.51M2016-12-31: $4.19M2017-12-31: $2.64M2018-12-31: $2.74M2019-12-31: $6.33M2020-12-31: $15.97M2021-12-31: $1.40M2022-12-31: $1.40M$1.40M
2011-12-31 Cost of Revenue (USD) 2022-12-31
Period endedCost of RevenueChange YoYSource filing
2022-12-31$1.40M-0.4%2024-03-29, From 2022-01-01
2021-12-31$1.40M-91.2%2023-04-07, From 2021-01-01
2020-12-31$15.97M+152.2%2022-03-23, From 2020-01-01
2019-12-31$6.33M+131.4%2022-03-23, From 2019-01-01
2018-12-31$2.74M+3.8%2021-03-04, From 2018-01-01
2017-12-31$2.64M-37.0%2020-02-24, From 2017-01-01
2016-12-31$4.19M-7.1%2019-02-27, From 2016-01-01
2015-12-31$4.51M+22.7%2018-02-23, From 2015-01-01
2014-12-31$3.67M+87.4%2017-02-28, From 2014-01-01
2013-12-31$1.96M+45.4%2016-02-26, From 2013-01-01
2012-12-31$1.35M+42.3%2015-03-12, From 2012-01-01
2011-12-31$947.1Kn/a2014-03-05, From 2011-01-01